AccuStem Sciences, Inc. (ACUT)
OTCMKTS · Delayed Price · Currency is USD
0.6993
+0.0957 (15.85%)
At close: Dec 24, 2025
AccuStem Sciences Market Cap
AccuStem Sciences has a market cap or net worth of $11.24 million as of December 24, 2025. Its market cap has increased by 93.74% in one year.
Market Cap
11.24M
Enterprise Value
11.27M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.70
Market Cap Chart
Since March 2, 2022, AccuStem Sciences's market cap has decreased from 20.42M to 11.24M, a decrease of -44.96%. That is a compound annual growth rate of -14.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 11.24M | 121.09% |
| Dec 31, 2024 | 5.08M | -28.40% |
| Dec 29, 2023 | 7.10M | -53.62% |
| Dec 30, 2022 | 15.31M | -25.04% |
| Mar 2, 2022 | 20.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 722.39M |
| Elite Pharmaceuticals | 515.15M |
| Northwest Biotherapeutics | 401.29M |
| American Oncology Network | 394.40M |
| CytoDyn | 357.58M |
| Silence Therapeutics | 304.66M |
| Nika Pharmaceuticals | 291.10M |